Possible antidotes for suicide risk: What should we tell our patients?

Sean Bordelon, Stephen H. Dinwiddie*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Suicidal behaviors and communications are obvious concerns for psychiatrists. Whereas the infrequency of completed suicide makes it hard to study and the alternative construct of “suicidality” is not uniformly defined across studies, associations can be found between treatments in the psychiatrist’s toolbox and possible suicide-protective effects. This review identifies several candidate treatments-psychotherapy, antidepressants, lithium, anticonvulsant agents, electroconvulsive therapy, and clozapine-and weighs their potential suicide-protective effects against their known risks.

Original languageEnglish (US)
Pages (from-to)466-470
Number of pages5
JournalPsychiatric Annals
Volume47
Issue number9
DOIs
StatePublished - Sep 2017

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Possible antidotes for suicide risk: What should we tell our patients?'. Together they form a unique fingerprint.

Cite this